Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG
Novo Holdings A/S reported a 9.00% stake in Hemab Therapeutics Holdings, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Novo Holdings A/S reported a 9.00% stake in Hemab Therapeutics Holdings, Inc., 4,180,550 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 9.00%
- Shares
- 4,180,550
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Novo Holdings A/S | 9.00% | 4,180,550 |
Source
Related
- Hemab Therapeutics Holdings, Inc.
- Novo Holdings A/S
- Hemab Therapeutics Holdings, Inc. shareholders
- Schedule 13G · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G · Capital International Investors · Aug 12, 2026
- Schedule 13G · Invus Public Equities, L.P. · Aug 7, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026
- Schedule 13G · Sofinnova Crossover II SLP · Aug 5, 2026